Tyler Jacks
Director/Board Member chez THERMO FISHER SCIENTIFIC
Fortune : 9 M $ au 29/02/2024
Profil
Founder of T2 Biosystems, Inc. and Dragonfly Therapeutics, Inc., Tyler E.
Jacks currently is President & Director at Commonwealth Cancer Consortium, Inc. He is also on the board of Amgen, Inc. and Thermo Fisher Scientific, Inc. and Professor at Massachusetts Institute of Technology.
He previously held the position of Director at David H.
Koch Institute for Integrative Cancer Research and Chairman for National Cancer Institute.
He received an undergraduate degree from Harvard University and a doctorate from The University of California, San Francisco.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
24/05/2023 | 8 059 ( 0,00% ) | 5 M $ | 29/02/2024 | |
AMGEN INC.
0,00% | 19/05/2023 | 14 868 ( 0,00% ) | 4 M $ | 29/02/2024 |
Postes actifs de Tyler Jacks
Sociétés | Poste | Début |
---|---|---|
THERMO FISHER SCIENTIFIC | Director/Board Member | 26/05/2009 |
AMGEN INC. | Director/Board Member | 01/01/2012 |
Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/2007 |
Commonwealth Cancer Consortium, Inc. | President | 01/02/2021 |
Anciens postes connus de Tyler Jacks
Sociétés | Poste | Fin |
---|---|---|
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Director/Board Member | 01/01/2021 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Chairman | 01/01/2016 |
T2 BIOSYSTEMS, INC. | Founder | 01/01/2013 |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Founder | - |
Formation de Tyler Jacks
Harvard University | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
AMGEN INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
T2 BIOSYSTEMS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Commercial Services |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Health Technology |
Commonwealth Cancer Consortium, Inc. |